Rank | Gene Set | Z-score |
---|---|---|
1 | neurofilament cytoskeleton organization (GO:0060052) | 4.98719405 |
2 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.88108432 |
3 | regulation of cholesterol esterification (GO:0010872) | 4.66836932 |
4 | cellular ketone body metabolic process (GO:0046950) | 4.65397714 |
5 | membrane assembly (GO:0071709) | 4.64040193 |
6 | peripheral nervous system neuron development (GO:0048935) | 4.63441832 |
7 | cell migration in hindbrain (GO:0021535) | 4.24943354 |
8 | detection of temperature stimulus (GO:0016048) | 4.21697370 |
9 | phospholipid efflux (GO:0033700) | 4.09861961 |
10 | ketone body metabolic process (GO:1902224) | 4.06837652 |
11 | high-density lipoprotein particle remodeling (GO:0034375) | 4.06025184 |
12 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.97567452 |
13 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.97567452 |
14 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.91767544 |
15 | cardiac myofibril assembly (GO:0055003) | 3.86511550 |
16 | muscle filament sliding (GO:0030049) | 3.77881217 |
17 | actin-myosin filament sliding (GO:0033275) | 3.77881217 |
18 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.77437669 |
19 | myofibril assembly (GO:0030239) | 3.76383165 |
20 | reverse cholesterol transport (GO:0043691) | 3.74687404 |
21 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.69317892 |
22 | membrane raft organization (GO:0031579) | 3.65006794 |
23 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.53600193 |
24 | actin-mediated cell contraction (GO:0070252) | 3.52080992 |
25 | blood vessel maturation (GO:0001955) | 3.51222176 |
26 | regulation of relaxation of muscle (GO:1901077) | 3.48707075 |
27 | sarcomere organization (GO:0045214) | 3.43595824 |
28 | regulation of skeletal muscle contraction (GO:0014819) | 3.43300330 |
29 | low-density lipoprotein particle clearance (GO:0034383) | 3.39445036 |
30 | protein targeting to plasma membrane (GO:0072661) | 3.36531543 |
31 | negative regulation of platelet activation (GO:0010544) | 3.34288478 |
32 | neuronal action potential propagation (GO:0019227) | 3.34254065 |
33 | plasma membrane repair (GO:0001778) | 3.30151106 |
34 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.29549281 |
35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.29462944 |
36 | plasma lipoprotein particle assembly (GO:0034377) | 3.25756427 |
37 | ovulation from ovarian follicle (GO:0001542) | 3.22335986 |
38 | phospholipid homeostasis (GO:0055091) | 3.20621304 |
39 | regulation of actin filament-based movement (GO:1903115) | 3.19683562 |
40 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.19594246 |
41 | fatty acid transmembrane transport (GO:1902001) | 3.19127688 |
42 | proline transport (GO:0015824) | 3.17484319 |
43 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.15301750 |
44 | serotonin receptor signaling pathway (GO:0007210) | 3.12458638 |
45 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.10657819 |
46 | positive regulation of axon extension (GO:0045773) | 3.10148462 |
47 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.09122117 |
48 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.09041715 |
49 | negative regulation of lipase activity (GO:0060192) | 3.06810522 |
50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04572724 |
51 | surfactant homeostasis (GO:0043129) | 3.04333279 |
52 | relaxation of cardiac muscle (GO:0055119) | 3.00204796 |
53 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.99208038 |
54 | regulation of cell communication by electrical coupling (GO:0010649) | 2.98680595 |
55 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.98441185 |
56 | negative regulation of dendrite development (GO:2000171) | 2.98413313 |
57 | otic vesicle formation (GO:0030916) | 2.94539144 |
58 | embryonic digestive tract morphogenesis (GO:0048557) | 2.93384767 |
59 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.92181788 |
60 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.89696093 |
61 | carnitine shuttle (GO:0006853) | 2.89158859 |
62 | innervation (GO:0060384) | 2.87335509 |
63 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.86518250 |
64 | phasic smooth muscle contraction (GO:0014821) | 2.86359590 |
65 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.85682707 |
66 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.85632620 |
67 | regulation of striated muscle contraction (GO:0006942) | 2.85036740 |
68 | chemical homeostasis within a tissue (GO:0048875) | 2.85035250 |
69 | regulation of platelet aggregation (GO:0090330) | 2.84860762 |
70 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.83488000 |
71 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.82941215 |
72 | protein-lipid complex assembly (GO:0065005) | 2.82297689 |
73 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.82083615 |
74 | plasma lipoprotein particle remodeling (GO:0034369) | 2.81028235 |
75 | protein-lipid complex remodeling (GO:0034368) | 2.81028235 |
76 | macromolecular complex remodeling (GO:0034367) | 2.81028235 |
77 | hemidesmosome assembly (GO:0031581) | 2.80527498 |
78 | cell communication involved in cardiac conduction (GO:0086065) | 2.78464361 |
79 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.78176085 |
80 | negative regulation of protein activation cascade (GO:2000258) | 2.75855745 |
81 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.75423338 |
82 | glomerular filtration (GO:0003094) | 2.75122260 |
83 | lung vasculature development (GO:0060426) | 2.72929417 |
84 | regulation of vasculogenesis (GO:2001212) | 2.72336083 |
85 | negative regulation of protein autophosphorylation (GO:0031953) | 2.72297280 |
86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.71387174 |
87 | membrane budding (GO:0006900) | 2.71175022 |
88 | cholesterol efflux (GO:0033344) | 2.70984465 |
89 | cardiac muscle hypertrophy (GO:0003300) | 2.70882651 |
90 | actomyosin structure organization (GO:0031032) | 2.70373640 |
91 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.69162920 |
92 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.68234937 |
93 | inositol phosphate catabolic process (GO:0071545) | 2.67822940 |
94 | tachykinin receptor signaling pathway (GO:0007217) | 2.67820749 |
95 | galactose catabolic process (GO:0019388) | 2.67771336 |
96 | positive regulation of glomerulus development (GO:0090193) | 2.66098848 |
97 | cardiac muscle contraction (GO:0060048) | 2.65782085 |
98 | growth hormone receptor signaling pathway (GO:0060396) | 2.65291246 |
99 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.64612393 |
100 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.64435762 |
101 | renal filtration (GO:0097205) | 2.64055496 |
102 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.64039817 |
103 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.63871080 |
104 | negative regulation of protein localization to cell surface (GO:2000009) | 2.62929699 |
105 | triglyceride catabolic process (GO:0019433) | 2.62915265 |
106 | positive regulation of muscle hypertrophy (GO:0014742) | 2.62450969 |
107 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.62450969 |
108 | nephron epithelium morphogenesis (GO:0072088) | 2.62378506 |
109 | nephron tubule morphogenesis (GO:0072078) | 2.62378506 |
110 | hypotonic response (GO:0006971) | 2.61790794 |
111 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.61426852 |
112 | regulation of digestive system process (GO:0044058) | 2.61126287 |
113 | carnitine transport (GO:0015879) | 2.60303816 |
114 | amino-acid betaine transport (GO:0015838) | 2.60303816 |
115 | one-carbon compound transport (GO:0019755) | 2.59096734 |
116 | regulation of cardiac muscle contraction (GO:0055117) | 2.58726186 |
117 | plasma lipoprotein particle clearance (GO:0034381) | 2.57838641 |
118 | toxin metabolic process (GO:0009404) | 2.56714698 |
119 | striated muscle hypertrophy (GO:0014897) | 2.56482195 |
120 | valine metabolic process (GO:0006573) | 2.55721260 |
121 | endocrine hormone secretion (GO:0060986) | 2.55439405 |
122 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.54775854 |
123 | axon extension (GO:0048675) | 2.54277167 |
124 | establishment of mitochondrion localization (GO:0051654) | 2.54261413 |
125 | bile acid biosynthetic process (GO:0006699) | 2.53751709 |
126 | cardiac muscle cell development (GO:0055013) | 2.53413384 |
127 | positive regulation of vasculogenesis (GO:2001214) | 2.52639324 |
128 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.52506439 |
129 | artery development (GO:0060840) | 2.52401068 |
130 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.52219423 |
131 | respiratory tube development (GO:0030323) | 2.51312080 |
132 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.51298254 |
133 | response to inactivity (GO:0014854) | 2.50566885 |
134 | intermediate filament organization (GO:0045109) | 2.50550556 |
135 | negative regulation of sodium ion transport (GO:0010766) | 2.50403420 |
136 | * neuronal action potential (GO:0019228) | 2.49642758 |
137 | relaxation of muscle (GO:0090075) | 2.49627914 |
138 | regulation of action potential (GO:0098900) | 2.49398256 |
139 | mammary gland development (GO:0030879) | 2.48972186 |
140 | negative regulation of cation channel activity (GO:2001258) | 2.46805394 |
141 | brown fat cell differentiation (GO:0050873) | 2.46619507 |
142 | retinal ganglion cell axon guidance (GO:0031290) | 2.46472656 |
143 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.46161257 |
144 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.46083139 |
145 | regulation of membrane repolarization (GO:0060306) | 2.45829807 |
146 | somite development (GO:0061053) | 2.45655360 |
147 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.45471065 |
148 | endothelial cell differentiation (GO:0045446) | 2.45175652 |
149 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.45157375 |
150 | striated muscle contraction (GO:0006941) | 2.43684680 |
151 | galactose metabolic process (GO:0006012) | 2.43478769 |
152 | interkinetic nuclear migration (GO:0022027) | 2.43423218 |
153 | establishment of monopolar cell polarity (GO:0061162) | 2.43028587 |
154 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.43028587 |
155 | actin filament-based movement (GO:0030048) | 2.42781555 |
156 | regulation of hippo signaling (GO:0035330) | 2.42610476 |
157 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.42480071 |
158 | SMAD protein signal transduction (GO:0060395) | 2.42330120 |
159 | renal tubule morphogenesis (GO:0061333) | 2.42049745 |
160 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.41985542 |
161 | prostate gland growth (GO:0060736) | 2.41176128 |
162 | regulation of muscle hypertrophy (GO:0014743) | 2.40679737 |
163 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.39836169 |
164 | mitochondrion transport along microtubule (GO:0047497) | 2.39836169 |
165 | acylglycerol catabolic process (GO:0046464) | 2.39766703 |
166 | neutral lipid catabolic process (GO:0046461) | 2.39766703 |
167 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.39672404 |
168 | response to vitamin E (GO:0033197) | 2.39229614 |
169 | muscle tissue morphogenesis (GO:0060415) | 2.38336588 |
170 | suckling behavior (GO:0001967) | 2.37809047 |
171 | cGMP-mediated signaling (GO:0019934) | 2.35929266 |
172 | regulation of metalloenzyme activity (GO:0048552) | 2.35540689 |
173 | cardiac muscle cell action potential (GO:0086001) | 2.35237694 |
174 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.35143155 |
175 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.34060472 |
176 | triglyceride biosynthetic process (GO:0019432) | 2.33907299 |
177 | regulation of protein kinase A signaling (GO:0010738) | 2.32941281 |
178 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.32673408 |
179 | regulation of cholesterol storage (GO:0010885) | 2.32389283 |
180 | intracellular lipid transport (GO:0032365) | 2.31974008 |
181 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.27859441 |
182 | positive regulation of fatty acid oxidation (GO:0046321) | 2.27789355 |
183 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.27702333 |
184 | lymphangiogenesis (GO:0001946) | 2.27637734 |
185 | lung lobe morphogenesis (GO:0060463) | 2.27122710 |
186 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.27054221 |
187 | cell communication by electrical coupling (GO:0010644) | 2.26881303 |
188 | neutral lipid biosynthetic process (GO:0046460) | 2.25540625 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.19913716 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.54026068 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.40250781 |
4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37569246 |
5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.36590138 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.29154320 |
7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.22565967 |
8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.22363274 |
9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.20560460 |
10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.14261822 |
11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08640615 |
12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.06407098 |
13 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.06390803 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.03587464 |
15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.03438440 |
16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.02095314 |
17 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00972027 |
18 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00972027 |
19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96671047 |
20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95735140 |
21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.95371099 |
22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95305561 |
23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.82880075 |
24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.82232064 |
25 | CJUN_26792858_Chip-Seq_BT549_Human | 1.81098602 |
26 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.80547871 |
27 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.75962285 |
28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75539124 |
29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73397316 |
30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.70214656 |
31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69503960 |
32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.69111289 |
33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.68039008 |
34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66964509 |
35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64882700 |
36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64659212 |
37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60727206 |
38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60564271 |
39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59194021 |
40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58204321 |
41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57949523 |
42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57136937 |
43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.55823727 |
44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55750736 |
45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53366585 |
46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53236753 |
47 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.48131103 |
48 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47587751 |
49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.47220733 |
50 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.47025370 |
51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46792219 |
52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45553829 |
53 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42721429 |
54 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.41044830 |
55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.40920865 |
56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40548168 |
57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39052509 |
58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37725334 |
59 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.37178559 |
60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37039303 |
61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36397501 |
62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36249574 |
63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36249574 |
64 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35974313 |
65 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.35371102 |
66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35040387 |
67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34932731 |
68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30478122 |
69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30305163 |
70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28959344 |
71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28763738 |
72 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.24459364 |
73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24247338 |
74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23834765 |
75 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.23501228 |
76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23059080 |
77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22879201 |
78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22345188 |
79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21207701 |
80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20583044 |
81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20538130 |
82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19525788 |
83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18830750 |
84 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18830750 |
85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18363786 |
86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18300996 |
87 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17866602 |
88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.17603377 |
89 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17551765 |
90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16059271 |
91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15385980 |
92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13875721 |
93 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13772752 |
94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12593175 |
95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11654829 |
96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11316846 |
97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09929821 |
98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09564824 |
99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09402720 |
100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09304780 |
101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08997418 |
102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08433216 |
103 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08182153 |
104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08166078 |
105 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08146123 |
106 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08146123 |
107 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07643771 |
108 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07126300 |
109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06094504 |
110 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05646204 |
111 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05454600 |
112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05124741 |
113 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04993161 |
114 | EWS_26573619_Chip-Seq_HEK293_Human | 1.04980187 |
115 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04703578 |
116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04469402 |
117 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04277065 |
118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03929085 |
119 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.03841852 |
120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02606909 |
121 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02535551 |
122 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.01581718 |
123 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01481054 |
124 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01307404 |
125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00929579 |
126 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00841136 |
127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97705399 |
128 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97625706 |
129 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96997484 |
130 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96775447 |
131 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96652630 |
132 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95747391 |
133 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94724816 |
134 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93800501 |
135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93547115 |
136 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93510468 |
137 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93398226 |
138 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91373519 |
139 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90283573 |
140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89762367 |
141 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88342471 |
142 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88279514 |
143 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.87731021 |
144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87639314 |
145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87591284 |
146 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87591284 |
147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85497402 |
148 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84940015 |
149 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84204729 |
150 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83549311 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009780_abnormal_chondrocyte_physiolo | 4.38780686 |
2 | MP0002735_abnormal_chemical_nociception | 4.18249539 |
3 | MP0003191_abnormal_cellular_cholesterol | 3.88099843 |
4 | MP0004858_abnormal_nervous_system | 3.87430453 |
5 | MP0008438_abnormal_cutaneous_collagen | 3.86244896 |
6 | MP0003705_abnormal_hypodermis_morpholog | 3.30610778 |
7 | MP0003045_fibrosis | 2.99666183 |
8 | MP0002837_dystrophic_cardiac_calcinosis | 2.95626486 |
9 | MP0005275_abnormal_skin_tensile | 2.94510246 |
10 | MP0004270_analgesia | 2.91467977 |
11 | MP0005670_abnormal_white_adipose | 2.88720148 |
12 | MP0003950_abnormal_plasma_membrane | 2.87232973 |
13 | MP0004147_increased_porphyrin_level | 2.84118419 |
14 | MP0004272_abnormal_basement_membrane | 2.78513540 |
15 | MP0004145_abnormal_muscle_electrophysio | 2.65915797 |
16 | MP0003646_muscle_fatigue | 2.64582334 |
17 | MP0001968_abnormal_touch/_nociception | 2.57195122 |
18 | MP0008995_early_reproductive_senescence | 2.42621496 |
19 | MP0006276_abnormal_autonomic_nervous | 2.33791698 |
20 | MP0002736_abnormal_nociception_after | 2.27749615 |
21 | MP0000751_myopathy | 2.24027030 |
22 | MP0005360_urolithiasis | 2.19067766 |
23 | MP0009840_abnormal_foam_cell | 2.16949538 |
24 | MP0002734_abnormal_mechanical_nocicepti | 2.08734511 |
25 | MP0004130_abnormal_muscle_cell | 2.02821353 |
26 | MP0003828_pulmonary_edema | 1.94990285 |
27 | MP0001879_abnormal_lymphatic_vessel | 1.88909751 |
28 | MP0002733_abnormal_thermal_nociception | 1.86124355 |
29 | MP0010368_abnormal_lymphatic_system | 1.83998628 |
30 | MP0000013_abnormal_adipose_tissue | 1.79252094 |
31 | MP0001958_emphysema | 1.77218695 |
32 | MP0000749_muscle_degeneration | 1.75853653 |
33 | MP0002332_abnormal_exercise_endurance | 1.73513234 |
34 | MP0006054_spinal_hemorrhage | 1.71375165 |
35 | MP0003137_abnormal_impulse_conducting | 1.64885378 |
36 | MP0005666_abnormal_adipose_tissue | 1.56055580 |
37 | MP0003724_increased_susceptibility_to | 1.55096324 |
38 | MP0002106_abnormal_muscle_physiology | 1.51555561 |
39 | MP0005369_muscle_phenotype | 1.50532512 |
40 | MP0003136_yellow_coat_color | 1.50075628 |
41 | MP0006138_congestive_heart_failure | 1.48465022 |
42 | MP0005551_abnormal_eye_electrophysiolog | 1.46941479 |
43 | MP0002638_abnormal_pupillary_reflex | 1.46265648 |
44 | MP0001970_abnormal_pain_threshold | 1.45096060 |
45 | MP0002127_abnormal_cardiovascular_syste | 1.45028368 |
46 | MP0001984_abnormal_olfaction | 1.40983490 |
47 | MP0000750_abnormal_muscle_regeneration | 1.38995863 |
48 | MP0005503_abnormal_tendon_morphology | 1.36934291 |
49 | MP0002876_abnormal_thyroid_physiology | 1.34939367 |
50 | MP0004883_abnormal_blood_vessel | 1.34875111 |
51 | MP0009384_cardiac_valve_regurgitation | 1.34868724 |
52 | MP0002102_abnormal_ear_morphology | 1.33665728 |
53 | MP0002168_other_aberrant_phenotype | 1.32168841 |
54 | MP0005385_cardiovascular_system_phenoty | 1.28681259 |
55 | MP0001544_abnormal_cardiovascular_syste | 1.28681259 |
56 | MP0002972_abnormal_cardiac_muscle | 1.26710801 |
57 | MP0008775_abnormal_heart_ventricle | 1.24982043 |
58 | MP0002138_abnormal_hepatobiliary_system | 1.24292810 |
59 | MP0010030_abnormal_orbit_morphology | 1.23876667 |
60 | MP0008004_abnormal_stomach_pH | 1.18141719 |
61 | MP0003195_calcinosis | 1.13543777 |
62 | MP0003279_aneurysm | 1.13240282 |
63 | MP0001542_abnormal_bone_strength | 1.12894620 |
64 | MP0005375_adipose_tissue_phenotype | 1.11763753 |
65 | MP0008260_abnormal_autophagy | 1.11583587 |
66 | MP0005253_abnormal_eye_physiology | 1.09298736 |
67 | MP0002269_muscular_atrophy | 1.07398358 |
68 | MP0001348_abnormal_lacrimal_gland | 1.07205339 |
69 | MP0002067_abnormal_sensory_capabilities | 1.07037686 |
70 | MP0004036_abnormal_muscle_relaxation | 1.06826660 |
71 | MP0005620_abnormal_muscle_contractility | 1.06767101 |
72 | MP0005085_abnormal_gallbladder_physiolo | 1.05822165 |
73 | MP0005167_abnormal_blood-brain_barrier | 1.05766287 |
74 | MP0003566_abnormal_cell_adhesion | 1.04102948 |
75 | MP0004782_abnormal_surfactant_physiolog | 1.03528970 |
76 | MP0003329_amyloid_beta_deposits | 1.03480476 |
77 | MP0000383_abnormal_hair_follicle | 1.02837718 |
78 | MP0000462_abnormal_digestive_system | 1.02413338 |
79 | MP0003567_abnormal_fetal_cardiomyocyte | 1.01916919 |
80 | MP0004084_abnormal_cardiac_muscle | 1.01726156 |
81 | MP0002909_abnormal_adrenal_gland | 1.01614163 |
82 | MP0005535_abnormal_body_temperature | 1.00117982 |
83 | MP0001664_abnormal_digestion | 0.99292677 |
84 | MP0003011_delayed_dark_adaptation | 0.99032740 |
85 | MP0010386_abnormal_urinary_bladder | 0.98053101 |
86 | MP0004185_abnormal_adipocyte_glucose | 0.97169033 |
87 | MP0001486_abnormal_startle_reflex | 0.96882458 |
88 | MP0005171_absent_coat_pigmentation | 0.96384496 |
89 | MP0003283_abnormal_digestive_organ | 0.95452964 |
90 | MP0002272_abnormal_nervous_system | 0.95272462 |
91 | MP0009115_abnormal_fat_cell | 0.95224981 |
92 | MP0004484_altered_response_of | 0.94518978 |
93 | MP0004215_abnormal_myocardial_fiber | 0.94425786 |
94 | MP0002184_abnormal_innervation | 0.94094076 |
95 | MP0000343_altered_response_to | 0.93649185 |
96 | MP0002234_abnormal_pharynx_morphology | 0.93122079 |
97 | MP0005164_abnormal_response_to | 0.92585078 |
98 | MP0001756_abnormal_urination | 0.92029032 |
99 | MP0002938_white_spotting | 0.90894281 |
100 | MP0000681_abnormal_thyroid_gland | 0.90028793 |
101 | MP0004087_abnormal_muscle_fiber | 0.87516976 |
102 | MP0002133_abnormal_respiratory_system | 0.86108529 |
103 | MP0005388_respiratory_system_phenotype | 0.86108529 |
104 | MP0005330_cardiomyopathy | 0.85700383 |
105 | MP0000631_abnormal_neuroendocrine_gland | 0.85578026 |
106 | MP0002108_abnormal_muscle_morphology | 0.85302536 |
107 | MP0002971_abnormal_brown_adipose | 0.85084281 |
108 | MP0000230_abnormal_systemic_arterial | 0.84818813 |
109 | MP0009046_muscle_twitch | 0.84711255 |
110 | MP0005334_abnormal_fat_pad | 0.84564934 |
111 | MP0000003_abnormal_adipose_tissue | 0.84432041 |
112 | MP0000747_muscle_weakness | 0.83977368 |
113 | MP0003119_abnormal_digestive_system | 0.83637287 |
114 | MP0002128_abnormal_blood_circulation | 0.83636186 |
115 | MP0002009_preneoplasia | 0.83090190 |
116 | MP0003880_abnormal_central_pattern | 0.82066229 |
117 | MP0001177_atelectasis | 0.80502800 |
118 | MP0002295_abnormal_pulmonary_circulatio | 0.80380743 |
119 | MP0000759_abnormal_skeletal_muscle | 0.79935976 |
120 | MP0003690_abnormal_glial_cell | 0.79900743 |
121 | MP0003634_abnormal_glial_cell | 0.79886049 |
122 | MP0006072_abnormal_retinal_apoptosis | 0.79578699 |
123 | MP0001661_extended_life_span | 0.79474098 |
124 | MP0008877_abnormal_DNA_methylation | 0.79304467 |
125 | MP0010630_abnormal_cardiac_muscle | 0.79135012 |
126 | MP0004142_abnormal_muscle_tone | 0.78889753 |
127 | MP0001501_abnormal_sleep_pattern | 0.77127019 |
128 | MP0003252_abnormal_bile_duct | 0.76385675 |
129 | MP0000516_abnormal_urinary_system | 0.76273402 |
130 | MP0005367_renal/urinary_system_phenotyp | 0.76273402 |
131 | MP0002751_abnormal_autonomic_nervous | 0.75846188 |
132 | MP0003942_abnormal_urinary_system | 0.75211304 |
133 | MP0000920_abnormal_myelination | 0.74797323 |
134 | MP0005595_abnormal_vascular_smooth | 0.73757662 |
135 | MP0009250_abnormal_appendicular_skeleto | 0.73196247 |
136 | MP0005165_increased_susceptibility_to | 0.71832743 |
137 | MP0003091_abnormal_cell_migration | 0.71312226 |
138 | MP0001299_abnormal_eye_distance/ | 0.71243645 |
139 | MP0004085_abnormal_heartbeat | 0.70767466 |
140 | MP0008569_lethality_at_weaning | 0.70174598 |
141 | MP0000767_abnormal_smooth_muscle | 0.67954732 |
142 | MP0004133_heterotaxia | 0.67697042 |
143 | MP0003633_abnormal_nervous_system | 0.65494258 |
144 | MP0010329_abnormal_lipoprotein_level | 0.65367335 |
145 | MP0001270_distended_abdomen | 0.64744137 |
146 | MP0004859_abnormal_synaptic_plasticity | 0.61057802 |
147 | MP0002166_altered_tumor_susceptibility | 0.60718123 |
148 | MP0004811_abnormal_neuron_physiology | 0.59407006 |
149 | MP0002118_abnormal_lipid_homeostasis | 0.59240214 |
150 | MP0000534_abnormal_ureter_morphology | 0.58167621 |
151 | MP0000604_amyloidosis | 0.58085513 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ulnar claw (HP:0001178) | 7.16185270 |
2 | Growth hormone excess (HP:0000845) | 5.19379707 |
3 | Insidious onset (HP:0003587) | 4.73822805 |
4 | Termporal pattern (HP:0011008) | 4.73822805 |
5 | Action tremor (HP:0002345) | 4.63034157 |
6 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.61530208 |
7 | Pheochromocytoma (HP:0002666) | 4.38066209 |
8 | Sudden death (HP:0001699) | 4.01277522 |
9 | Chronic hepatic failure (HP:0100626) | 3.97683005 |
10 | Neuroendocrine neoplasm (HP:0100634) | 3.93485607 |
11 | Spontaneous abortion (HP:0005268) | 3.92447631 |
12 | Oligomenorrhea (HP:0000876) | 3.81550062 |
13 | Acanthosis nigricans (HP:0000956) | 3.66905643 |
14 | Bundle branch block (HP:0011710) | 3.65693635 |
15 | Myokymia (HP:0002411) | 3.58076014 |
16 | Calf muscle hypertrophy (HP:0008981) | 3.55327626 |
17 | Abnormality of the calf musculature (HP:0001430) | 3.50014661 |
18 | Foot dorsiflexor weakness (HP:0009027) | 3.45762148 |
19 | Hypothermia (HP:0002045) | 3.45739737 |
20 | Steppage gait (HP:0003376) | 3.44346246 |
21 | Camptodactyly of toe (HP:0001836) | 3.38962385 |
22 | Type 1 muscle fiber predominance (HP:0003803) | 3.38652808 |
23 | Hammertoe (HP:0001765) | 3.37225799 |
24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.36673760 |
25 | Syncope (HP:0001279) | 3.36349676 |
26 | Glucose intolerance (HP:0000833) | 3.29754926 |
27 | Atrial fibrillation (HP:0005110) | 3.26027823 |
28 | Increased connective tissue (HP:0009025) | 3.24324962 |
29 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 3.23596524 |
30 | Distal arthrogryposis (HP:0005684) | 3.21569395 |
31 | Hyporeflexia of lower limbs (HP:0002600) | 3.10129624 |
32 | Nemaline bodies (HP:0003798) | 3.08132185 |
33 | Cerebral hemorrhage (HP:0001342) | 3.05514409 |
34 | Broad metatarsal (HP:0001783) | 3.04875678 |
35 | Submucous cleft hard palate (HP:0000176) | 3.03313279 |
36 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.01755897 |
37 | Abnormality of the foot musculature (HP:0001436) | 3.01713374 |
38 | Muscle fiber inclusion bodies (HP:0100299) | 3.00203419 |
39 | Onion bulb formation (HP:0003383) | 3.00079980 |
40 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.99275111 |
41 | Hyperventilation (HP:0002883) | 2.99250182 |
42 | Hypercortisolism (HP:0001578) | 2.96253831 |
43 | Primary atrial arrhythmia (HP:0001692) | 2.95473113 |
44 | Bradycardia (HP:0001662) | 2.93374471 |
45 | Myotonia (HP:0002486) | 2.88936967 |
46 | Tachypnea (HP:0002789) | 2.86311587 |
47 | Abnormality of pain sensation (HP:0010832) | 2.85603257 |
48 | Impaired pain sensation (HP:0007328) | 2.85603257 |
49 | Supraventricular tachycardia (HP:0004755) | 2.74390852 |
50 | Xerostomia (HP:0000217) | 2.72971589 |
51 | Decreased motor nerve conduction velocity (HP:0003431) | 2.71983966 |
52 | Supraventricular arrhythmia (HP:0005115) | 2.70312628 |
53 | Hypoalphalipoproteinemia (HP:0003233) | 2.68719606 |
54 | Bone cyst (HP:0012062) | 2.66951582 |
55 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.65648242 |
56 | Distal sensory impairment (HP:0002936) | 2.58636588 |
57 | Abnormal glucose tolerance (HP:0001952) | 2.58556223 |
58 | Decreased circulating renin level (HP:0003351) | 2.57458258 |
59 | Abnormal pancreas size (HP:0012094) | 2.53579387 |
60 | Absent phalangeal crease (HP:0006109) | 2.53501977 |
61 | Lymphangioma (HP:0100764) | 2.53129421 |
62 | Overgrowth (HP:0001548) | 2.51606053 |
63 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.51285615 |
64 | Heart block (HP:0012722) | 2.51228737 |
65 | Keratoconus (HP:0000563) | 2.50489820 |
66 | Increased corneal curvature (HP:0100692) | 2.50489820 |
67 | Ventricular tachycardia (HP:0004756) | 2.49891022 |
68 | Abnormality of alanine metabolism (HP:0010916) | 2.49552154 |
69 | Hyperalaninemia (HP:0003348) | 2.49552154 |
70 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49552154 |
71 | Flexion contracture of toe (HP:0005830) | 2.47579848 |
72 | Joint contractures involving the joints of the feet (HP:0100492) | 2.47579848 |
73 | Hypolipoproteinemia (HP:0010981) | 2.47133270 |
74 | Atonic seizures (HP:0010819) | 2.45402059 |
75 | Neoplasm of the heart (HP:0100544) | 2.42497059 |
76 | Hyperpituitarism (HP:0010514) | 2.37041768 |
77 | Left ventricular hypertrophy (HP:0001712) | 2.35375775 |
78 | Impaired proprioception (HP:0010831) | 2.33547828 |
79 | Abnormal hemoglobin (HP:0011902) | 2.33291305 |
80 | Thoracolumbar scoliosis (HP:0002944) | 2.32423369 |
81 | Prominent supraorbital ridges (HP:0000336) | 2.32413812 |
82 | Febrile seizures (HP:0002373) | 2.31331427 |
83 | Respiratory distress (HP:0002098) | 2.28812327 |
84 | Abnormality of the renal cortex (HP:0011035) | 2.28635268 |
85 | Lower limb muscle weakness (HP:0007340) | 2.28430516 |
86 | Cutaneous finger syndactyly (HP:0010554) | 2.27973451 |
87 | Prolonged QT interval (HP:0001657) | 2.27863541 |
88 | Spinal rigidity (HP:0003306) | 2.24087610 |
89 | Retinal atrophy (HP:0001105) | 2.22833784 |
90 | Aqueductal stenosis (HP:0002410) | 2.21815137 |
91 | Abnormal finger flexion creases (HP:0006143) | 2.21686345 |
92 | Limited hip movement (HP:0008800) | 2.21183402 |
93 | Potter facies (HP:0002009) | 2.20258287 |
94 | Facial shape deformation (HP:0011334) | 2.20258287 |
95 | Abnormal atrioventricular conduction (HP:0005150) | 2.18502871 |
96 | Pancreatic cysts (HP:0001737) | 2.18253162 |
97 | Large hands (HP:0001176) | 2.18138789 |
98 | Abnormality of the ischium (HP:0003174) | 2.17852750 |
99 | Pigmentary retinal degeneration (HP:0001146) | 2.15862619 |
100 | Abnormality of the vocal cords (HP:0008777) | 2.13733509 |
101 | Ventricular arrhythmia (HP:0004308) | 2.13611980 |
102 | Cerebral aneurysm (HP:0004944) | 2.13295939 |
103 | Pancreatic fibrosis (HP:0100732) | 2.12866783 |
104 | Hypertriglyceridemia (HP:0002155) | 2.12208146 |
105 | Difficulty running (HP:0009046) | 2.11724170 |
106 | Tubulointerstitial fibrosis (HP:0005576) | 2.10831801 |
107 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.10806099 |
108 | Round ear (HP:0100830) | 2.09420170 |
109 | Striae distensae (HP:0001065) | 2.09386964 |
110 | Fragile skin (HP:0001030) | 2.08519712 |
111 | Concave nail (HP:0001598) | 2.07729811 |
112 | Lipoatrophy (HP:0100578) | 2.07142339 |
113 | Genital tract atresia (HP:0001827) | 2.07025033 |
114 | Increased CSF protein (HP:0002922) | 2.04312536 |
115 | Rectal prolapse (HP:0002035) | 2.03829634 |
116 | Vaginal atresia (HP:0000148) | 2.03559894 |
117 | Epidermoid cyst (HP:0200040) | 2.03481198 |
118 | Congenital stationary night blindness (HP:0007642) | 2.02532645 |
119 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02021235 |
120 | Orthostatic hypotension (HP:0001278) | 2.01308155 |
121 | Chin dimple (HP:0010751) | 2.00815713 |
122 | Cutaneous syndactyly (HP:0012725) | 1.99726565 |
123 | Focal seizures (HP:0007359) | 1.99343183 |
124 | Aortic aneurysm (HP:0004942) | 1.99062557 |
125 | Intestinal atresia (HP:0011100) | 1.97687567 |
126 | Aplasia of the musculature (HP:0100854) | 1.97666039 |
127 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.97115346 |
128 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.96910815 |
129 | Decreased muscle mass (HP:0003199) | 1.96865694 |
130 | Nephronophthisis (HP:0000090) | 1.96856718 |
131 | Muscle fiber splitting (HP:0003555) | 1.95889761 |
132 | Dilated cardiomyopathy (HP:0001644) | 1.92769572 |
133 | Palpitations (HP:0001962) | 1.92393574 |
134 | Difficulty climbing stairs (HP:0003551) | 1.92011589 |
135 | Renal cortical cysts (HP:0000803) | 1.91991459 |
136 | Ankle contracture (HP:0006466) | 1.90811573 |
137 | Atrophic scars (HP:0001075) | 1.90645339 |
138 | Molar tooth sign on MRI (HP:0002419) | 1.90432245 |
139 | Abnormality of midbrain morphology (HP:0002418) | 1.90432245 |
140 | Facial diplegia (HP:0001349) | 1.90314325 |
141 | Postural tremor (HP:0002174) | 1.90157840 |
142 | True hermaphroditism (HP:0010459) | 1.90003663 |
143 | Metaphyseal dysplasia (HP:0100255) | 1.88785767 |
144 | Hip contracture (HP:0003273) | 1.88271640 |
145 | Focal motor seizures (HP:0011153) | 1.88036359 |
146 | Long toe (HP:0010511) | 1.87272905 |
147 | Medial flaring of the eyebrow (HP:0010747) | 1.86917542 |
148 | Hematochezia (HP:0002573) | 1.85668934 |
149 | Amyloidosis (HP:0011034) | 1.84439033 |
150 | Abnormality of the renal medulla (HP:0100957) | 1.84016699 |
151 | Lumbar hyperlordosis (HP:0002938) | 1.83418995 |
152 | Thyroid-stimulating hormone excess (HP:0002925) | 1.83285358 |
153 | Premature rupture of membranes (HP:0001788) | 1.83195268 |
154 | Aortic dissection (HP:0002647) | 1.82970917 |
155 | Abnormal EKG (HP:0003115) | 1.82912199 |
156 | Distal lower limb muscle weakness (HP:0009053) | 1.80890689 |
157 | Intrahepatic cholestasis (HP:0001406) | 1.80566685 |
158 | Ulnar deviation of the wrist (HP:0003049) | 1.80525621 |
159 | Anterior segment dysgenesis (HP:0007700) | 1.79438290 |
160 | EMG: myopathic abnormalities (HP:0003458) | 1.79084568 |
161 | Abnormality of the parathyroid morphology (HP:0011766) | 1.78432382 |
162 | Wrist flexion contracture (HP:0001239) | 1.77572208 |
163 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.77431212 |
164 | Hypobetalipoproteinemia (HP:0003563) | 1.77089943 |
165 | Asymmetric septal hypertrophy (HP:0001670) | 1.77020062 |
166 | Upper limb muscle weakness (HP:0003484) | 1.76946844 |
167 | Areflexia of lower limbs (HP:0002522) | 1.76168641 |
168 | Fasciculations (HP:0002380) | 1.75954068 |
169 | Preaxial foot polydactyly (HP:0001841) | 1.75942781 |
170 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.75526559 |
171 | Muscle stiffness (HP:0003552) | 1.73744581 |
172 | Follicular hyperkeratosis (HP:0007502) | 1.73065434 |
173 | Failure to thrive in infancy (HP:0001531) | 1.72923079 |
174 | Hypoventilation (HP:0002791) | 1.72767680 |
175 | Right ventricular cardiomyopathy (HP:0011663) | 1.72602162 |
176 | Dysautonomia (HP:0002459) | 1.72533943 |
177 | Exercise-induced muscle cramps (HP:0003710) | 1.71146326 |
178 | Neonatal respiratory distress (HP:0002643) | 1.70753933 |
179 | Knee flexion contracture (HP:0006380) | 1.70543743 |
180 | Abnormality of the renal collecting system (HP:0004742) | 1.70452158 |
181 | Interstitial pulmonary disease (HP:0006530) | 1.70097087 |
182 | Short tibia (HP:0005736) | 1.69396371 |
183 | Shawl scrotum (HP:0000049) | 1.69195165 |
184 | Abnormality of proline metabolism (HP:0010907) | 1.68665963 |
185 | Hydroxyprolinuria (HP:0003080) | 1.68665963 |
186 | Atrioventricular block (HP:0001678) | 1.68355268 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LMTK2 | 4.35010950 |
2 | NEK9 | 3.82858903 |
3 | SIK3 | 3.79399412 |
4 | TIE1 | 2.80688747 |
5 | MINK1 | 2.68454357 |
6 | GRK1 | 2.48545256 |
7 | NTRK3 | 2.38698076 |
8 | MAPKAPK3 | 2.33145308 |
9 | CASK | 2.24746925 |
10 | PIK3CG | 2.01297504 |
11 | FER | 1.93942461 |
12 | BCR | 1.91494580 |
13 | NTRK1 | 1.89534546 |
14 | EPHB1 | 1.89037042 |
15 | CAMK1D | 1.80567963 |
16 | PHKG1 | 1.78708496 |
17 | PHKG2 | 1.78708496 |
18 | EPHA3 | 1.78552058 |
19 | DMPK | 1.76699417 |
20 | TNIK | 1.73174392 |
21 | TAOK3 | 1.71581109 |
22 | MAP3K2 | 1.68649500 |
23 | FGFR3 | 1.66462031 |
24 | ADRBK2 | 1.65383532 |
25 | LATS2 | 1.64045111 |
26 | RET | 1.60325191 |
27 | PAK3 | 1.57551322 |
28 | LIMK1 | 1.55797778 |
29 | ACVR1B | 1.47054635 |
30 | SGK2 | 1.46140311 |
31 | LATS1 | 1.44994200 |
32 | KSR2 | 1.42412585 |
33 | MAP2K1 | 1.41352732 |
34 | MAP2K4 | 1.40160123 |
35 | EPHB2 | 1.37468780 |
36 | CCNB1 | 1.37218585 |
37 | MYLK | 1.35552407 |
38 | MAP3K4 | 1.35084022 |
39 | MUSK | 1.32854633 |
40 | SGK223 | 1.28949516 |
41 | SGK494 | 1.28949516 |
42 | MST4 | 1.28931024 |
43 | WNK1 | 1.28633405 |
44 | WNK3 | 1.26634544 |
45 | GRK5 | 1.25964195 |
46 | MAP3K12 | 1.25307521 |
47 | AKT3 | 1.24447470 |
48 | MARK1 | 1.23868062 |
49 | CAMK1G | 1.23512875 |
50 | FRK | 1.22387608 |
51 | RPS6KA2 | 1.22218334 |
52 | PDK4 | 1.17574950 |
53 | PDK3 | 1.17574950 |
54 | NLK | 1.17352196 |
55 | TGFBR2 | 1.12576811 |
56 | TRIB3 | 1.12078762 |
57 | PTK2B | 1.11448359 |
58 | MAPK15 | 1.11216100 |
59 | OXSR1 | 1.11134076 |
60 | FGFR4 | 1.09074224 |
61 | SGK3 | 1.07014113 |
62 | SIK1 | 1.04958823 |
63 | MAP3K9 | 1.02457557 |
64 | NUAK1 | 0.94522883 |
65 | PRKD3 | 0.94308099 |
66 | MAP2K7 | 0.94077852 |
67 | PRKCH | 0.93104237 |
68 | FGFR2 | 0.90341765 |
69 | CAMKK2 | 0.85764934 |
70 | GRK7 | 0.85377051 |
71 | MAP4K2 | 0.84054886 |
72 | PBK | 0.81713951 |
73 | MST1R | 0.81700184 |
74 | MATK | 0.81661113 |
75 | TRPM7 | 0.78243523 |
76 | TXK | 0.78154613 |
77 | BCKDK | 0.77994642 |
78 | CDK19 | 0.77851824 |
79 | STK39 | 0.77430679 |
80 | CAMK2A | 0.75470469 |
81 | PRKAA2 | 0.74570607 |
82 | STK24 | 0.72850750 |
83 | PIK3CA | 0.72715958 |
84 | ZAK | 0.72213676 |
85 | TGFBR1 | 0.72158223 |
86 | PRKG1 | 0.71958801 |
87 | RIPK1 | 0.70870838 |
88 | PDGFRA | 0.66845917 |
89 | TTN | 0.65377568 |
90 | PRKD1 | 0.64720012 |
91 | PRKACB | 0.63113098 |
92 | PRKG2 | 0.62660444 |
93 | PRKACA | 0.62326623 |
94 | STK3 | 0.61671663 |
95 | MAPK7 | 0.60953070 |
96 | CAMK2D | 0.60612628 |
97 | ROCK1 | 0.59121082 |
98 | ADRBK1 | 0.58181207 |
99 | PDGFRB | 0.57137151 |
100 | SCYL2 | 0.56470179 |
101 | JAK1 | 0.56414536 |
102 | ERBB4 | 0.56248423 |
103 | PDK2 | 0.54256496 |
104 | KIT | 0.54011207 |
105 | KSR1 | 0.52375349 |
106 | MAPK11 | 0.52137893 |
107 | MAP2K2 | 0.52030856 |
108 | MAPK12 | 0.51659962 |
109 | MKNK2 | 0.51462211 |
110 | PTK2 | 0.51448632 |
111 | PKN1 | 0.50443995 |
112 | PINK1 | 0.50417024 |
113 | MAP3K3 | 0.49844133 |
114 | CDK5 | 0.49742826 |
115 | PRKCE | 0.49415197 |
116 | BMPR1B | 0.48823096 |
117 | PNCK | 0.48714928 |
118 | CAMK2G | 0.48279949 |
119 | WNK4 | 0.47901586 |
120 | CAMK1 | 0.47192856 |
121 | PRKCG | 0.47048271 |
122 | ERBB2 | 0.45760152 |
123 | MAPK13 | 0.45099292 |
124 | PRKAA1 | 0.44929936 |
125 | PDPK1 | 0.43484834 |
126 | PRKACG | 0.43050163 |
127 | MARK3 | 0.42531116 |
128 | SRC | 0.42095169 |
129 | GSK3A | 0.41565013 |
130 | NTRK2 | 0.41091854 |
131 | ROCK2 | 0.41026068 |
132 | IGF1R | 0.40912364 |
133 | MAP3K1 | 0.40873358 |
134 | RPS6KA6 | 0.40770060 |
135 | STK4 | 0.39808203 |
136 | CSNK1G1 | 0.39047039 |
137 | STK38L | 0.37650119 |
138 | PRKCA | 0.37180661 |
139 | TNK2 | 0.35385113 |
140 | DAPK2 | 0.34763084 |
141 | PLK2 | 0.34749292 |
142 | MARK2 | 0.34613549 |
143 | YES1 | 0.34262808 |
144 | PAK6 | 0.33751112 |
145 | STK11 | 0.33590891 |
146 | MAP3K14 | 0.33411058 |
147 | INSRR | 0.32906712 |
148 | MAP3K7 | 0.32738121 |
149 | CAMK4 | 0.32557566 |
150 | PAK2 | 0.32400211 |
151 | OBSCN | 0.32287249 |
152 | DDR2 | 0.32221121 |
153 | CSNK1D | 0.31467286 |
154 | MAPK4 | 0.31274741 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.46224998 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.36053905 |
3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.25368397 |
4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.23597612 |
5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.23091620 |
6 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.20386117 |
7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17646544 |
8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.17137791 |
9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.16542078 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07307256 |
11 | Taste transduction_Homo sapiens_hsa04742 | 1.97501949 |
12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96597639 |
13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.90263583 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83996086 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.76768580 |
16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.75588677 |
17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.75231167 |
18 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.72842509 |
19 | Phototransduction_Homo sapiens_hsa04744 | 1.66844289 |
20 | ABC transporters_Homo sapiens_hsa02010 | 1.53885402 |
21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53198821 |
22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52797725 |
23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46932938 |
24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.45389304 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39312962 |
26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.38574735 |
27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37915527 |
28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37747737 |
29 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.32659758 |
30 | Peroxisome_Homo sapiens_hsa04146 | 1.30750793 |
31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29236640 |
32 | Renin secretion_Homo sapiens_hsa04924 | 1.27830843 |
33 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.24549539 |
34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.23601105 |
35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22173386 |
36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.20520539 |
37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.19319542 |
38 | Focal adhesion_Homo sapiens_hsa04510 | 1.16585975 |
39 | Melanoma_Homo sapiens_hsa05218 | 1.14379452 |
40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.11720832 |
41 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11417761 |
42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.10388201 |
43 | Insulin resistance_Homo sapiens_hsa04931 | 1.09862058 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09304561 |
45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08634630 |
46 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08071155 |
47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07323947 |
48 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.07228680 |
49 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.05410579 |
50 | Salivary secretion_Homo sapiens_hsa04970 | 1.05252708 |
51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05221169 |
52 | Tight junction_Homo sapiens_hsa04530 | 1.04114652 |
53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.03985554 |
54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03892991 |
55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03778066 |
56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00163985 |
57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.99735130 |
58 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99259492 |
59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97667041 |
60 | Mineral absorption_Homo sapiens_hsa04978 | 0.95999416 |
61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95642492 |
62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95435473 |
63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95199647 |
64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95176152 |
65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94391719 |
66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94120555 |
67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93641132 |
68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93612908 |
69 | Insulin secretion_Homo sapiens_hsa04911 | 0.91859896 |
70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89597362 |
71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.88556445 |
72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88144022 |
73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87097601 |
74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87009217 |
75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85587415 |
76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85051684 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84780300 |
78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84447240 |
79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83410054 |
80 | Bile secretion_Homo sapiens_hsa04976 | 0.83324410 |
81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83321729 |
82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81992249 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80901324 |
84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79242710 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.78455078 |
86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78395159 |
87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77069042 |
88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76957474 |
89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75810855 |
90 | Phagosome_Homo sapiens_hsa04145 | 0.75232184 |
91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74794154 |
92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74264266 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73951993 |
94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73197894 |
95 | Glioma_Homo sapiens_hsa05214 | 0.72944697 |
96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72838982 |
97 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.72452089 |
98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72259700 |
99 | Gap junction_Homo sapiens_hsa04540 | 0.72049259 |
100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71897330 |
101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71075065 |
102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69543824 |
103 | Axon guidance_Homo sapiens_hsa04360 | 0.68217144 |
104 | Amoebiasis_Homo sapiens_hsa05146 | 0.67891821 |
105 | Melanogenesis_Homo sapiens_hsa04916 | 0.67158401 |
106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66977226 |
107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66918307 |
108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64887164 |
109 | Salmonella infection_Homo sapiens_hsa05132 | 0.63663090 |
110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62766976 |
111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62748487 |
112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61358317 |
113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59630932 |
114 | Morphine addiction_Homo sapiens_hsa05032 | 0.59461371 |
115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59414697 |
116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59085347 |
117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59015710 |
118 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58260281 |
119 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58010182 |
120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56745447 |
121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56745296 |
122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55744669 |
123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55552072 |
124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55383294 |
125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53514811 |
126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53148734 |
127 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.51165781 |
128 | Long-term potentiation_Homo sapiens_hsa04720 | 0.51082871 |
129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50657853 |
130 | Adherens junction_Homo sapiens_hsa04520 | 0.50302365 |
131 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50154163 |
132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49099209 |
133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48813302 |
134 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48705730 |
135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48683254 |
136 | Platelet activation_Homo sapiens_hsa04611 | 0.48561431 |
137 | Prion diseases_Homo sapiens_hsa05020 | 0.48368420 |
138 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47337535 |
139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47267259 |
140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46692883 |
141 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46655510 |
142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46407125 |
143 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46063271 |
144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45851983 |
145 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45128502 |
146 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44996901 |
147 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44836454 |
148 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.42193605 |
149 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41587938 |
150 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41069730 |
151 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40332625 |
152 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39620158 |
153 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39104661 |
154 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38585007 |
155 | Nicotine addiction_Homo sapiens_hsa05033 | 0.34350930 |